Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Oct 19, 2021

Amiodarone monitoring: are existing guidelines outdated? In this interview, A. John Camm, MD, FACC and Uma Narasimhan Srivatsa MBBS, FACC, with Tiffany Y. Hu, MD, discuss Amiodarone monitoring in 2021.

 

Like what you hear? Get 20 episodes/month with CME/MOC credit! www.acc.org/ACCEL

Subscribe on Apple Podcasts |


Oct 12, 2021

As the number of women of childbearing age with heart disease grows, the importance of safe and effective birth control counseling for pregnancy planning is more important than ever. Which contraceptive methods are optimal for women with cardiovascular disease?

In this interview, Kathryn J. Lindley, MD, FACC and Laxmi...


Oct 6, 2021

This study investigates the efficacy and safety of finerenone, compared with a placebo to reduce clinically important cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes when added to the standard of care, which includes glucose-lowering therapies, and...


Sep 28, 2021

This large, multicentre, randomized trial was conducted with patients at high risk for bleeding who had undergone biodegradable polymer sirolimus-eluting stent implantation to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events. And if so, whether it...


Sep 21, 2021

In this interview, Jeroen Bax, PhD, MD, FACC; Stefan Anker, MD, PhD; and Sherry-Ann Brown, MD, PhD, FACC, discuss the ESC Congress 2021 late breaker EMPEROR-Preserved, which evaluates the effect of empagliflozin for risk of cardiovascular death and hospitalisation for patients with heart failure and a preserved fraction with...